| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Simcere Pharmaceutical Holding Ltd.
|
893.479m | 34.42% | -44.953m | Apr 08 2026 |
| 2 |
Artking Global Ltd.
|
592.810m | 22.84% | — | Apr 08 2026 |
| 3 |
Ren (Jin Sheng)
|
123.626m | 4.76% | — | Apr 08 2026 |
| 4 |
Fortune Fountain Investment Ltd.
|
120.961m | 4.66% | — | Apr 08 2026 |
| 5 |
China Universal Asset Management Co., Ltd.
|
56.438m | 2.17% | +31.296m | Dec 31 2025 |
|
1
Simcere Pharmaceutical Holding Ltd.
|
34.42%
893.479m
|
|
2
Artking Global Ltd.
|
22.84%
592.810m
|
|
3
Ren (Jin Sheng)
|
4.76%
123.626m
|
|
4
Fortune Fountain Investment Ltd.
|
4.66%
120.961m
|
|
5
China Universal Asset Management Co., Ltd.
|
2.17%
56.438m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 68.86% of Simcere Pharmaceutical Group, with Simcere Pharmaceutical Holding Ltd. the biggest at 34.42%, followed by Artking Global Ltd. (22.84%) and Ren (Jin Sheng) (4.76%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


